Homocysteine Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting homocysteine clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Bengbu, Anhui, China, Bozhou, Anhui, China, Chengdu, Sichuan, China. Updated daily from ClinicalTrials.gov.


Homocysteine Trials at a Glance

8 actively recruiting trials for homocysteine are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Bengbu, Bozhou, and Chengdu. Lead sponsors running homocysteine studies include Far Eastern Memorial Hospital, Necmettin Erbakan University, and Dr Lisa Houghton.

Browse homocysteine trials by phase

Treatments under study

About Homocysteine Clinical Trials

Looking for clinical trials for Homocysteine? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Homocysteine trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Homocysteine clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Maternal Methyl-Nutrient Status and Infant Neurodevelopment Study

PregnancyNutritionDietary Quality+6 more
Far Eastern Memorial Hospital240 enrolled2 locationsNCT07568561
Recruiting

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Hypertension (HTN)Diastolic DysfunctionHyperhomocysteinemia
Necmettin Erbakan University500 enrolled1 locationNCT07480265
Recruiting

Longitudinal Study of Neurodegenerative Disorders

Gaucher DiseaseBatten DiseaseLeukodystrophy+24 more
University of Pittsburgh1,500 enrolled1 locationNCT03333200
Recruiting
Not Applicable

Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.

Hyperhomocysteinemia
S.LAB (SOLOWAYS)111 enrolled1 locationNCT06264570
Recruiting

Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients

Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
Sohag University120 enrolled1 locationNCT07017868
Recruiting
Phase 4

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Not Applicable

Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults

Homocysteine
Sun Yat-sen University220 enrolled1 locationNCT06363565
Recruiting

Breast-milk and infant nutrition study

Folic acid statusHuman milk folate concentrationOther nutritional indices (vitamins B6 and B12, choline, betaine, dimethylglycine, methioinine, homocysteine, cysteine, cystathionine, iron, zinc, and selenium)+1 more
Dr Lisa Houghton70 enrolled1 locationACTRN12612000656831